Finance

Vaxcyte to Host Webcast and Conference Call to Present Topline Results from Phase 1/2 Study of VAX-31, its 31-Valent Pneumococcal Conjugate Vaccine Candidate, in...

SAN CARLOS, Calif., Sept. 02, 2024 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect...

Gold prices hover near record highs ahead of key labor market data By Investing.com

Gold prices opened nearly unchanged amid the prospect of a rate cut by the Federal Reserve in September continues to be a major focus...

ICE Launches New Suite of Indices for Australian Residential Mortgage-Backed Securities Market By Investing.com

ATLANTA, NEW YORK, & SYDNEY--(BUSINESS WIRE)--Intercontinental Exchange (NYSE: ICE), a leading global provider of technology and data, today announced the launch of...

Dollar dips ahead of the key jobs report By Investing.com

The U.S. dollar saw a modest decline but stayed close to its nearly two-week high, with investor attention turning to the forthcoming U.S....

Oil prices pop as Libyan oil exports remained halted By Investing.com

oil futures opened modestly higher after recording three consecutive weeks of losses. Oil prices have been under pressure lately, influenced by concerns...

US futures edge higher as focus shifts to job market By Investing.com

US equity futures opened modestly higher on Monday afternoon with the rising 0.1%, while climbed 0.3%. The remained relatively unchanged, as...

Velan Inc. Signs Main Services Agreement With GEH SMR Technologies Canada Ltd. By Investing.com

MONTREAL, Sept. 02, 2024 (GLOBE NEWSWIRE) -- Velan Inc. (TSX: VLN) (Velan or the Company), a world-leading manufacturer of industrial valves, announced today...

Hamas says hostage guards in Gaza have been operating under new instructions By Reuters

By Nidal al-Mughrabi and Jaidaa Taha CAIRO (Reuters) -Hamas' armed wing said on Monday that since June the group has been operating...

Praxis Precision Medicines to Announce Topline Data from the Phase 2 EMBOLD Study of Relutrigine (PRAX-562) in SCN2A and SCN8A Developmental and Epileptic Encephalopathies...

BOSTON, Mass., Sept. 02, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the...
1...5,4215,4225,423...7,645Page 5,422 of 7,645

Latest articles

spot_imgspot_img